Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadi Abbara

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|September 9, 2023
3-Methylmethcathinone Intoxication: Discrepancies Between Blood Concentrations and Clinical Outcomes-A Short CommunicationGuillaume Drevin, Antoine Baudriller, Severine Ferec, et al.
Pharmaceutics|August 29, 2024
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the LiteratureGuillaume Drevin, Maria Pena-Martin, Aurélien Bauduin, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 10, 2018
Enzalutamide and analytical interferences in digoxin assaysMarie Deguigne, Marion Brunet, Chadi Abbara, et al.
Journal of Forensic Sciences|September 29, 2021
Lethal self-administration of propofol and atracuriumGuillaume Drevin, Marie Briet, Séverine Ferec, et al.
Plos Computational Biology|September 21, 2011
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian deliveryAnnabelle Ballesta, Sandrine Dulong, Chadi Abbara, et al.
Journal of Forensic and Legal Medicine|November 7, 2025
Assessment of psoas muscle as an alternative matrix for postmortem toxicological screening: qualitative agreement of xenobiotic detection with femoral and cardiac BloodSébastien Vivares, Chadi Abbara, Nathalie Jousset, et al.
Cancers|December 10, 2021
Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase<sup>®</sup> the WHO Global Database of Individual Case Safety ReportsAlexandre Crosnier, Chadi Abbara, Morgane Cellier, et al.
Fundamental & Clinical Pharmacology|March 5, 2014
Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing miceCéline Chu, Chadi Abbara, Mahamadou Tandia, et al.
Anti-Cancer Drugs|December 18, 2009
Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in miceBenoît Hosten, Chadi Abbara, Marion Cibert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2009
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipientsLaurence Bonhomme-Faivre, Véronique Picard, Faouzi Saliba, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|September 9, 2023
3-Methylmethcathinone Intoxication: Discrepancies Between Blood Concentrations and Clinical Outcomes-A Short CommunicationGuillaume Drevin, Antoine Baudriller, Severine Ferec, et al.
Pharmaceutics|August 29, 2024
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the LiteratureGuillaume Drevin, Maria Pena-Martin, Aurélien Bauduin, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 10, 2018
Enzalutamide and analytical interferences in digoxin assaysMarie Deguigne, Marion Brunet, Chadi Abbara, et al.
Journal of Forensic Sciences|September 29, 2021
Lethal self-administration of propofol and atracuriumGuillaume Drevin, Marie Briet, Séverine Ferec, et al.
Plos Computational Biology|September 21, 2011
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian deliveryAnnabelle Ballesta, Sandrine Dulong, Chadi Abbara, et al.
Journal of Forensic and Legal Medicine|November 7, 2025
Assessment of psoas muscle as an alternative matrix for postmortem toxicological screening: qualitative agreement of xenobiotic detection with femoral and cardiac BloodSébastien Vivares, Chadi Abbara, Nathalie Jousset, et al.
Cancers|December 10, 2021
Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase<sup>®</sup> the WHO Global Database of Individual Case Safety ReportsAlexandre Crosnier, Chadi Abbara, Morgane Cellier, et al.
Fundamental & Clinical Pharmacology|March 5, 2014
Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing miceCéline Chu, Chadi Abbara, Mahamadou Tandia, et al.
Anti-Cancer Drugs|December 18, 2009
Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in miceBenoît Hosten, Chadi Abbara, Marion Cibert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2009
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipientsLaurence Bonhomme-Faivre, Véronique Picard, Faouzi Saliba, et al.
Pageof 4